NCT05427786View on ClinicalTrials.gov

A Study to Evaluate the Impact of Pre-procedural Intracoronary Nicorandil Injection to PREVENT ReductioN of DecREased TIMI FLOW in Patients Who Undergoing Percutaneous Coronary Intervention for the Coronary Artery Disease

PHASE4RecruitingINTERVENTIONAL

Enrollment

460

Participants

Timeline

Start Date

December 14, 2022

Primary Completion Date

July 31, 2026

Study Completion Date

December 31, 2026

Conditions

No-Reflow PhenomenonCoronary Artery DiseasePercutaneous Coronary Intervention

Interventions

DRUG

Nicorandil

Administer 8cc or more of the prescribed drug according to randomization into the coronary artery before starting balloon therapy. The stent treatment method follows the standard treatment method.

Trial Locations (1)

Unknown

RECRUITING

Korea University Anam Hospital, Seoul

All Listed Sponsors

lead

Korea University Anam Hospital

OTHER